GUERRA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 6.833
EU - Europa 3.496
AS - Asia 1.440
SA - Sud America 126
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 11.919
Nazione #
US - Stati Uniti d'America 6.738
IT - Italia 1.036
SG - Singapore 560
DE - Germania 554
CN - Cina 509
SE - Svezia 434
RU - Federazione Russa 428
IE - Irlanda 344
UA - Ucraina 188
HK - Hong Kong 178
GB - Regno Unito 133
BR - Brasile 112
CA - Canada 87
FI - Finlandia 67
AT - Austria 66
VN - Vietnam 61
DK - Danimarca 59
FR - Francia 59
IN - India 38
BE - Belgio 27
NL - Olanda 27
ID - Indonesia 23
TR - Turchia 23
CZ - Repubblica Ceca 18
BG - Bulgaria 14
PL - Polonia 9
CH - Svizzera 8
IR - Iran 8
JP - Giappone 8
ES - Italia 6
RO - Romania 6
EU - Europa 5
KR - Corea 5
AU - Australia 4
CL - Cile 4
KG - Kirghizistan 4
MX - Messico 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
BD - Bangladesh 3
HU - Ungheria 3
LK - Sri Lanka 3
AZ - Azerbaigian 2
CO - Colombia 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
MK - Macedonia 2
SC - Seychelles 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
HN - Honduras 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.919
Città #
Ann Arbor 1.819
Fairfield 557
Woodbridge 461
Chandler 444
Singapore 408
Wilmington 395
Houston 390
Ashburn 333
Milan 333
Dublin 332
Frankfurt am Main 309
Dearborn 248
Seattle 229
Jacksonville 199
Cambridge 177
New York 174
Hong Kong 167
Santa Clara 155
Princeton 134
Lissone 104
Shanghai 97
Nanjing 76
Lawrence 61
Vienna 58
Altamura 52
Falls Church 43
San Diego 42
Guangzhou 41
Beijing 40
Fremont 38
Helsinki 34
Lachine 30
Boardman 28
Nanchang 27
Shenyang 27
Dong Ket 26
London 26
Council Bluffs 25
Moscow 25
Jinan 24
Brussels 23
Monza 22
Jakarta 21
Ottawa 21
Andover 18
Hebei 17
Segrate 16
Genoa 15
Kunming 15
Toronto 15
Brno 14
Nuremberg 14
Bari 13
Munich 13
Edmonton 12
Plovdiv 12
Pune 12
Tianjin 12
Dallas 10
São Paulo 10
Florence 9
Jiaxing 9
Los Angeles 9
Changsha 8
Leawood 8
Ningbo 8
Norwalk 8
Nürnberg 8
Rome 8
Biella 7
Chicago 7
Düsseldorf 7
Huizen 7
Newark 7
Pioltello 7
San Mateo 7
Cornate d'Adda 6
Detroit 6
Kiev 6
Kocaeli 6
Lanzhou 6
Lecco 6
Montréal 6
Paris 6
Redmond 6
Taizhou 6
Turin 6
Udine 6
Zhengzhou 6
Alessandria 5
Como 5
Desio 5
Gorgonzola 5
Hangzhou 5
Hefei 5
Mountain View 5
Napoli 5
Orta di Atella 5
Porto Alegre 5
Torino 5
Totale 8.750
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 403
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 335
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 334
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 317
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 302
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 284
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 260
Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results 254
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT 248
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 242
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 240
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer 239
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica 237
Erratum: ☆Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” (Critical Reviews in Oncology / Hematology (2019) 137 (154–164), (S1040842819300587), (10.1016/j.critrevonc.2019.03.006)) 234
Motion management in PET/CT: Technological solutions 231
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 224
Respiratory motion management in PET/CT: applications and clinical usefulness 224
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 222
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 209
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 207
Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDGPET in Treatment Planning 205
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 201
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 200
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 200
Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer 200
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 199
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 198
Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study 195
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 194
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 191
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 189
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination 188
Lung Regional Metabolic Activity and Gas Volume Changes Induced by Tidal Ventilation in Patients with Acute Lung Injury 186
Focal bone lesions in hiv-positive patient treated with tenofovir 180
Imaging of lung inflammation during severe influenza A: H1N1 177
Italian Multicenter Study on Accuracy of 18 F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma 172
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 167
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 167
FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial 163
Performance measurements for the PET/CT Discovery-600 using NEMA NU 2-2007 standards 160
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 160
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 158
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases 156
Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement? 154
A case of Melas (A3243G) on chronic dichloroacetate treatment 153
Tidal changes on CT and progression of ARDS 149
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 146
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 140
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 138
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 138
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 136
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 135
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 129
The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC) 124
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 118
Respiratory Gating and the performance of PET/CT in pulmonary lesions 106
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 105
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial 99
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial 94
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease 92
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study 90
The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma) 85
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial 80
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial 76
Immunoscintigraphy of ovarian cancer recurrences: comparison with surgical findings and CT scan or US results 67
Prognostic value of PET-CT after fi rst-line therapy in patients with follicular lymphoma: A pooled analysis of central scan review in three multicentre studies 66
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 65
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 61
Predictive value of pre-treatment FDG PET in patients with non-Hodgkin lymphoma treated with radioimmunotherapy: a systematic review 56
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial 52
Current status of FDG-PET/CT in staging of adult lymphoma 48
18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? 41
Hairy cell leukemia with an atypical extranodal presentation: A clinicopathological analysis of four cases 22
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation 18
Totale 12.435
Categoria #
all - tutte 43.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020291 0 0 0 0 0 0 0 0 0 126 124 41
2020/20212.081 76 82 203 229 172 195 178 231 171 199 150 195
2021/20221.250 140 159 142 109 69 81 68 57 54 117 98 156
2022/20231.791 180 513 168 199 100 276 9 112 121 52 42 19
2023/20241.211 38 40 58 59 140 309 253 56 77 20 13 148
2024/20251.968 145 338 207 119 196 150 195 111 235 272 0 0
Totale 12.435